The association of baseline psychiatric comorbidity with healthcare utilization, status epilepticus, and all-cause mortality in adults with epilepsy: an exploratory cohort study

Psychiatric comorbidity is common among adults with epilepsy and may influence subsequent healthcare use and clinical outcomes. We examined its association with recorded mortality, status epilepticus, and healthcare utilization during the first year after a first recorded qualifying epilepsy event. We conducted a retrospective cohort study using the TriNetX Global Collaborative Network (171 contributing healthcare organizations), from January 1, 2015, to January 1, 2025. Adults aged ≥ 18 years with a first recorded qualifying epilepsy event (ICD-10-CM G40) followed by a recorded antiseizure medication on or after the index event and within nine months were classified according to the presence or absence of selected baseline psychiatric disorders (ICD-10 F20–F48) recorded during the five years preceding or on the index date, and 1:1 propensity-score matched on measured demographic, comorbidity, procedure, and antiseizure-medication covariates. A single baseline matched cohort was analyzed with Cox proportional-hazards models across an initial (days 1–90) and a subsequent landmark (days 91–365) post-index window, reporting hazard ratios (HRs) with 95% confidence intervals (CIs). The study was exploratory, without adjustment for multiple comparisons. After propensity-score matching, 75,895 patients were included in each cohort. Baseline psychiatric comorbidity was associated with higher recorded emergency and inpatient utilization in both windows (emergency HR 1.353 [95% CI 1.271–1.441] initial, 1.446 [1.362–1.536] subsequent; inpatient HR 1.162 [1.107–1.219] initial, 1.131 [1.061–1.205] subsequent). No statistically significant association was detected with status epilepticus (initial HR 0.746 [0.471–1.182]; subsequent 0.811 [0.608–1.080]), although event counts were low and estimates imprecise. Recorded mortality was lower in the initial window (HR 0.834 [0.793–0.877]) and attenuated toward the null in the subsequent window (HR 0.939 [0.884–0.998]); this inverse association is most consistent with selection, observability, ascertainment, and residual-confounding limitations rather than a protective effect. Baseline psychiatric comorbidity was associated with greater recorded acute healthcare utilization, particularly emergency care among adults with a first recorded qualifying epilepsy event. The status-epilepticus findings were inconclusive, and the inverse recorded-mortality association should not be interpreted as protective. These exploratory findings are hypothesis-generating; replication using validated incident-epilepsy definitions, aligned eligibility and follow-up, equivalent pre-index observability, and more complete mortality ascertainment is warranted.

Authors

Institutions

Publication Details

Journal
BMC Neurology
Published
2026-10-15
DOI
https://doi.org/10.1186/s12883-026-05502-3
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The association of baseline psychiatric comorbidity with healthcare utilization, status epilepticus, and all-cause mortality in adults with epilepsy: an exploratory cohort study

Yasmin Negida, Yousef Hawas, Abdelrahman Alsherbini, Hazem S. Ghaith et al.
BMC Neurology
Epilepsy research and treatment
article

The association of baseline psychiatric comorbidity with healthcare utilization, status epilepticus, and all-cause mortality in adults with epilepsy: an exploratory cohort study

Yasmin Negida, Yousef Hawas, Abdelrahman Alsherbini, Hazem S. Ghaith, Anwar Zahran, Moaz Elsayed Abouelmagd, Ahmed S.A Osman
article en

Abstract

Psychiatric comorbidity is common among adults with epilepsy and may influence subsequent healthcare use and clinical outcomes. We examined its association with recorded mortality, status epilepticus, and healthcare utilization during the first year after a first recorded qualifying epilepsy event. We conducted a retrospective cohort study using the TriNetX Global Collaborative Network (171 contributing healthcare organizations), from January 1, 2015, to January 1, 2025. Adults aged ≥ 18 years with a first recorded qualifying epilepsy event (ICD-10-CM G40) followed by a recorded antiseizure medication on or after the index event and within nine months were classified according to the presence or absence of selected baseline psychiatric disorders (ICD-10 F20–F48) recorded during the five years preceding or on the index date, and 1:1 propensity-score matched on measured demographic, comorbidity, procedure, and antiseizure-medication covariates. A single baseline matched cohort was analyzed with Cox proportional-hazards models across an initial (days 1–90) and a subsequent landmark (days 91–365) post-index window, reporting hazard ratios (HRs) with 95% confidence intervals (CIs). The study was exploratory, without adjustment for multiple comparisons. After propensity-score matching, 75,895 patients were included in each cohort. Baseline psychiatric comorbidity was associated with higher recorded emergency and inpatient utilization in both windows (emergency HR 1.353 [95% CI 1.271–1.441] initial, 1.446 [1.362–1.536] subsequent; inpatient HR 1.162 [1.107–1.219] initial, 1.131 [1.061–1.205] subsequent). No statistically significant association was detected with status epilepticus (initial HR 0.746 [0.471–1.182]; subsequent 0.811 [0.608–1.080]), although event counts were low and estimates imprecise. Recorded mortality was lower in the initial window (HR 0.834 [0.793–0.877]) and attenuated toward the null in the subsequent window (HR 0.939 [0.884–0.998]); this inverse association is most consistent with selection, observability, ascertainment, and residual-confounding limitations rather than a protective effect. Baseline psychiatric comorbidity was associated with greater recorded acute healthcare utilization, particularly emergency care among adults with a first recorded qualifying epilepsy event. The status-epilepticus findings were inconclusive, and the inverse recorded-mortality association should not be interpreted as protective. These exploratory findings are hypothesis-generating; replication using validated incident-epilepsy definitions, aligned eligibility and follow-up, equivalent pre-index observability, and more complete mortality ascertainment is warranted.

BMC Neurology
Cairo University (EG), Oregon Health & Science University (US), An-Najah National University (PS), Virginia Commonwealth University (US), Tanta University (EG), Yale University (US), Minia University (EG)
Good health and well-being
Openalex Percentile: Top 13%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.